IMPURITY PROFILING OF MYCOPHENOLATE MOFETIL WITH THE ASSISSTANCE OF DESIRABILITY FUNCTION IN METHOD DEVELOPMENT
- 15 June 2011
- journal article
- research article
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 34 (12) , 1014-1035
Abstract
Multicriteria decision making methodology in combination with experimental design has been applied for optimization of stability-indicating LC/DAD method of Mycophenolate mofetil and its degradation products. Via fractional factorial design variables with statistically significant impact on retention parameters of the investigated substances were defined and then thoroughly optimized toward four chromatographic responses combining central composition design and desirability function. The separation was achieved on Chromolith column (C18e, 100 × 4.6 mm) with the mobile phase consisted of acetonitrile—0.015 M KH2PO4 (pH 4.4) (28:72, v/v). The flow rate of the mobile phase was 2 mL/min and the detection was performed using PDA detector at 215 nm. The method has been suitably modified for LC/MS/MS analysis. The ammonium-acetate buffer was used instead of phosphate buffer and pH of the water phase was adjusted with acetic acid. The flow rate was 1 mL min−1. The substance was subjected to stress conditions (0.01 M NaOH, 1 M HCl, 3–30% H2O2, 70°C and day light). It resulted in formation of Mycophenolic acid and two oxidation products. The substance showed to be stable only towards photolysis. The LC/MS/MS values and fragmentation pattern of two unknown oxidation products were used in its characterization.Keywords
This publication has 39 references indexed in Scilit:
- Application of desirability-based multi(bi)-objective optimization in the design of selective arylpiperazine derivates for the 5-HT1A serotonin receptorEuropean Journal of Medicinal Chemistry, 2009
- Multicriteria optimization methodology in development of HPLC separation of mycophenolic acid and mycophenolic acid glucuronide in human urine and plasmaJournal of Pharmaceutical and Biomedical Analysis, 2009
- Simultaneous determination of mycophenolic acid and its glucuronides in human plasma using isocratic ion pair high-performance liquid chromatographyJournal of Pharmaceutical and Biomedical Analysis, 2008
- Development and validation of HPLC-DAD methods for the analysis of two novel iron chelators with potent anti-cancer activityJournal of Pharmaceutical and Biomedical Analysis, 2007
- The role of degradant profiling in active pharmaceutical ingredients and drug products☆Advanced Drug Delivery Reviews, 2007
- Validated specific HPLC method for determination of zidovudine during stability studiesJournal of Pharmaceutical and Biomedical Analysis, 2005
- HPLC determination of mycophenolic acid and mycophenolic acid glucuronide in human plasma with hybrid materialJournal of Pharmaceutical and Biomedical Analysis, 2004
- Simultaneous determination of free mycophenolic acid and its glucuronide in serum of patients under mycophenolate mophetil therapy by ion-pair reversed-phase liquid chromatography with diode array UV detectionJournal of Chromatography B, 2004
- Development of a high pressure liquid chromatography method for the determination of mycophenolic acid and its glucuronide metabolite in small volumes of plasma from paediatric patientsJournal of Pharmaceutical and Biomedical Analysis, 2004
- Development of validated stability-indicating assay methods—critical reviewJournal of Pharmaceutical and Biomedical Analysis, 2002